ArticleAnnals of African medicine2026
Gitelman Syndrome in the Sixth Decade: An Atypical Presentation with Severe Electrolyte Abnormalities and Genetic Heterogeneity.
Article in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A case analysis of Gitelman syndrome complicated with Sjögren's disease.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractGitelman syndrome (GS) is a rare autosomal recessive salt-losing tubulopathy characterized by hypokalemic metabolic alkalosis, hypomagnesemia, and hypocalciuria. While typically presenting in adolescence or early adulthood, atypical presentations and delayed diagnoses into later adulthood pose significant clinical challenges. We report a case of a 60-year-old female who presented with generalized weakness, lethargy, and severe electrolyte abnormalities, including profound hyponatremia (109 mmol/L), hypokalemia (2.91 mmol/L), hypocalcemia (<6.0 mg/dL), and hypomagnesemia (0.6 mg/dL). Laboratory investigations revealed metabolic alkalosis, hypochloremia, elevated parathyroid hormone (172.90 pg/ml), and inappropriate renal potassium wasting. Urinary studies showed relative hypocalciuria in the context of severe hypocalcemia. Genetic testing revealed no pathogenic variants in the SLC12A3 gene typically associated with GS, though variants of uncertain significance were identified in SLC22A12 and VPS33B genes. Management included aggressive electrolyte replacement, spironolactone, and dietary modifications, resulting in clinical improvement despite incomplete normalization of electrolytes. This case illustrates the complex clinical spectrum of GS, highlighting the importance of considering this diagnosis in older adults with unexplained electrolyte abnormalities. The absence of confirmatory SLC12A3 mutations despite classic biochemical features supports emerging evidence of genetic heterogeneity in GS. This case emphasizes the value of clinical diagnosis when genetic confirmation is lacking and the effectiveness of targeted symptomatic management. GS should be considered in the differential diagnosis of electrolyte abnormalities across all age groups. A high index of clinical suspicion and characteristic biochemical profile can guide diagnosis and management even in the absence of confirmatory genetic findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.